Friess Associates’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-267,164	Closed	-$12.9M	–	107
2020 Q2	$12.9M	Buy	267,164 +93,190	+54%	+$4.52M	1.21%	41
2020 Q1	$7.35M	Buy	+173,974	New	+$7.35M	0.73%	50